Patents/Assignees

Vertex Pharmaceuticals Incorporated

103 patents in portfolio

US12043843utility2024
Materials and Methods for Treatment of Hemoglobinopathies
0 cites
US12031150utility2024
Methods, Compositions and Kits for Increasing Genome Editing Efficiency
0 cites
US12024491utility2024
Processes for Making Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
0 cites
US12005127utility2024
DNA-PK Inhibitors
0 cites
US12006516utility2024
Differentiation of Pancreatic Endocrine Cells
0 cites
US11999971utility2024
Stem Cell Derived Islet Differentiation
0 cites
US11992506utility2024
Stem Cell Derived Pancreatic Islet Differentiation
0 cites
US11980633utility2024
Method for Treating Cancer Using a Combination of Dna-damaging Agents and DNA-PK Inhibitors
0 cites
US11951206utility2024
Cell Housing Device
0 cites
US11951212utility2024
Pharmaceutical Compositions for the Treatment of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases
0 cites
US11945795utility2024
Islet Cell Manufacturing Compositions and Methods of Use
0 cites
US11919887utility2024
Substituted Tetrahydrofurans as Modulators of Sodium Channels
0 cites
US11884672utility2024
Modulators of Alpha-1 Antitrypsin
0 cites
US11873300utility2024
Crystalline Forms of CFTR Modulators
0 cites
US11866446utility2024
Inhibitors of APOL1 and Methods of Using Same
0 cites
US11866450utility2024
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators
0 cites
US11834441utility2023
Substituted Tetrahydrofurans as Modulators of Sodium Channels
0 cites
US11827627utility2023
N-(hydroxyalkyl (hetero)aryl) Tetrahydrofuran Carboxamides as Modulators of Sodium Channels
0 cites
US11813267utility2023
DNA-PK Inhibitors
0 cites
US11807882utility2023
Modified Membrane Type Serine Protease 1 (MTSP-1) Polypeptides and Methods of Use
0 cites

← PreviousPage 4 of 6Next →